Mutations in the ␤-amyloid (A␤) sequence of the amyloid precursor protein gene (APP) present with variable disease phenotypes. While patients with the Dutch APP mutation (E693Q) have predominantly hemorrhagic strokes, Flemish APP (A692G) patients develop both strokes and Alzheimer's disease (AD). To determine whether these diverse clinical and pathological presentations are due to mutant A␤ or APP, we studied the effect of Flemish, Dutch, and wild-type A␤/APP on phosphorylation of specific tau epitopes observed in AD. No effect was observed in differentiated SH-SY5Y cells either stably expressing APP or treated with synthetic A␤ 12-42 . However, we did observe a paradoxical temporal difference in the neurotoxic potential of mutant and wild-type A␤. While long 24-h incubation at physiological levels of A␤ (2 M) showed a higher amount of apoptosis for Dutch A␤, a short 2-h incubation showed elevated apoptosis for Flemish and wild-type A␤. The altered aggregating properties of A␤, with Dutch A␤ aggregating faster and Flemish A␤ slower than wild type, elucidated a discrete two-phase A␤ neurotoxicity. We propose here that, at least in vitro, A␤ might be neurotoxic in an initial phase due to its soluble oligomeric or other early toxic A␤ intermediate(s), which is perhaps distinct from the late neurotoxicity incurred by aggregated larger assemblies of A␤. © 2002 Elsevier Science (USA)
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